Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
UBS
Novartis
Chubb
Cipla
Cantor Fitzgerald
Julphar
Chinese Patent Office
Mallinckrodt
Johnson and Johnson

Generated: January 16, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,993,830

« Back to Dashboard

Which drugs does patent 5,993,830 protect, and when does it expire?

Patent 5,993,830 protects ECOZA and is included in one NDA.

This patent has eighteen patent family members in fifteen countries.
Summary for Patent: 5,993,830
Title: Cosmetic skin preparation
Abstract:The present invention relates to a skin preparation comprising lipophilic and hydrophilic components, which is intended for application on skin. The skin preparation according to the present invention is characterized in that it exists as a two-phase system and it is capable of creating a semi-permeable membrane in the skin. The invention also relates to a process for the manufacture of the skin preparation as defined above, which is characterized in that the lipophilic components are dissolved in water in a separate container to be combined with hydrophilic components, which have been blended and brought to react in another vessel. Finally, the present invention also relates to different uses of the skin preparation as defined above.
Inventor(s): Freij; Goran (Stockholm, SE)
Assignee: Ponsus AB (Stockholm, SE)
Application Number:09/008,632
Patent Claim Types:
see list of patent claims
Compound; Formulation; Process; Use;

Drugs Protected by US Patent 5,993,830

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Chemo Research Sl ECOZA econazole nitrate AEROSOL, FOAM;TOPICAL 205175-001 Oct 24, 2013 RX Yes Yes ➤ Subscribe ➤ Subscribe Y METHOD OF ALLEVIATING A SKIN CONDITION ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,993,830

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Sweden9700129Jan 17, 1997

International Patents Family Members for US Patent 5,993,830

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 283684 ➤ Subscribe
Australia 5786198 ➤ Subscribe
Australia 744980 ➤ Subscribe
Brazil 9806774 ➤ Subscribe
Canada 2278521 ➤ Subscribe
China 1243431 ➤ Subscribe
Germany 69827929 ➤ Subscribe
Denmark 0961610 ➤ Subscribe
European Patent Office 0961610 ➤ Subscribe
Spain 2234091 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Healthtrust
QuintilesIMS
Fuji
Accenture
Merck
Chinese Patent Office
Harvard Business School
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot